A B S T RA C T This work addressed the problem of heterogeneity of immunoreactive insulin (IRI) in human plasma. Subjects with normal glucose tolerance were given 75 g of an oral glucose solution, followed in 30 min by an intravenous infusion of 30 g of arginine over 30 min. At the end of the infusion blood was withdrawn for analysis. IRI was extracted from plasma of individual subjects by immunosorbent columns and was fractionated by gel filtration, disc gel electrophoresis and isoelectric focusing. Human IRI components were identified by molecular size, immunoreactivity with a human proinsulin antibody, sensitivity to trypsin, and by comparison of electrophoretic mobility and isoelectric point with porcine pancreatic products, after suitable correction for electric charge and molecular weight differences.
A B S T RA C T This work addressed the problem of heterogeneity of immunoreactive insulin (IRI) in human plasma. Subjects with normal glucose tolerance were given 75 g of an oral glucose solution, followed in 30 min by an intravenous infusion of 30 g of arginine over 30 min. At the end of the infusion blood was withdrawn for analysis. IRI was extracted from plasma of individual subjects by immunosorbent columns and was fractionated by gel filtration, disc gel electrophoresis and isoelectric focusing. Human IRI components were identified by molecular size, immunoreactivity with a human proinsulin antibody, sensitivity to trypsin, and by comparison of electrophoretic mobility and isoelectric point with porcine pancreatic products, after suitable correction for electric charge and molecular weight differences.
The pattern of IRI heterogeneity was the same among six healthy subjects. Heterogeneity of proinsulin-size IRI in circulation was more marked than that of insulinsize material. Proinsulin and desdipeptide proinsulin were present in approximately equal amounts accompanied by minor amounts of split proinsulin and monodesamido-desdipeptide proinsulin. Insulin-size IRI contained over 80% insulin. Minor amounts of monodesamidoinsulin and diarginylinsulin were observed in some cases.
The types of IRI components observed in plasma are evidence in support of a physiologic role of trypsinand carboxypeptidase B-like enzymes in the conversion of proinsulin to insulin. Moreover, this study provides a base line for investigation of abnormalities in proinsulin-to-insulin conversion that may be associated with certain pathologic states.
INTRODUCTION
Insulin biosynthesis involves as last step(s) the proteolytic conversion of a single chain precursor proinsulin to the double chain product of insulin (1) (2) (3) . In the process a certain number of amino acid residues, e.g. 33 in the case of porcine (4) , and 35 in the case of human proinsulin (5, 6) , are excised from the middle of the chain of proinsulin (Fig. 1 ). The conversion of proinsulin takes place inside the secretory granule of the pancreatic 8-cell in the course of its maturation (7) (8) (9) . Proinsulin, insulin, and a variety of derivatives obtained by proteolytic modification thereof have been isolated from pancreas homogenates and their chemical, biological, and immunological properties have been characterized (10) (11) (12) (13) (14) (15) (16) . Also, the structure of the peptide excised from proinsulin during the conversion to insulin in the pancreas has been elucidated from a variety of species (4, 5, 9, 17) .
The same derivatives of proinsulin and insulin that were isolated from homogenized pancreas could also be obtained by in vitro enzymatic digestion ofproinsulin or insulin with exocrine pancreatic trypsin, chymotrypsin, and carboxypeptidase B, alone or in combination (18) . From these observations it was inferred that physiologic conversion of proinsulin to insulin involved the stepwise action of enzymes with similar specificities. This was strongly supported by studies of the conversion of selectively prelabeled proinsulin to insulin in a crude secretion granule fraction isolated from rat islets of Langerhans (9) .
Roth et al. (19) and Rubenstein et al. (20) first described a blood plasma component with a molecular weight higher than insulin that showed insulin immunoreactivity. This component became commonly thought of as proinsulin. Later, Lazarus et al. (21, 22) and Gutman et al. (23) pioneered the characterization of circulating insulin immunoreactive material by disc gel electrophoresis, and found, that the so-called proinsulin fraction was heterogeneous.
After improving and extending a number of tech- (26) . We also obtained two preparations ofcrude pancreatic human proinsulin (lots 615-1054 B-195-A and 615-1054 B-261-5), prepared by classical acid ethanol extraction, gel filtration and crystallization, from which proinsulin was further purified by preparative disc gel electrophoresis at pH 9.5. Antisera against electrophoretically pure porcine insulin were induced in guinea pigs according to Yalow and Berson (27, 28 Collection of blood specimens. Human subjects having followed a diet providing at least 300 g/day of carbohydrate for a minimum of 2 days arrived at the Clinical Research Center, University of Washington, after an overnight fast. A 19-gauge scalp vein needle was inserted into an antecubital vein and maintained with a slow saline infusion. After a 10-15-min rest, a 5-ml fasting blood sample was withdrawn from the intravenous line for serum glucose determination and analysis of total serum IRI. Each subject then consumed 75 g of glucose in solution. After 30 min another 5 ml blood sample was taken for serum glucose and IRI determinations.
This was followed by a 30-min infusion of an arginine solution (30 g in 300 ml of water) through the intravenous line using an infusion pump. Then 240 ml of blood was withdrawn over a period of 10 min, with 50 ml syringes containing 4 ml of an anticoagulant mixture (see below). Portions of the blood (40 ml) were immediately dispensed into 50 ml plastic centrifuge tubes. A final specimen (5 ml) was then taken for serum glucose and total IRI determination. No significant side effects were encountered.
Anticoagulant mixture. The activation of the presently recognized blood clotting enzymes was inhibited by a modified anticoagulant mixture originally described by Fujikawa et al. (31) . Table I gives the composition of this mixture and the ratio to be used with blood. EDTA and o-phenanthroline were added to inhibit metalloenzymes such as plasma carboxypeptidase B (32), plasma aminopeptidases (33) and metallo-endopeptidases potentially present in plasma or on cell surfaces. N-ethylmaleimide was added to inhibit sulfbydryl proteases potentially present and to mask free sulfhydryl groups, such as that of cysteine 34 in albumin (34) , to prevent disulfide interchange (35) .
Preparation of cell-free plasma. It was necessary to remove platelets as completely as possible to prevent aggregation and clogging of the immunosorbent column. Breakage of cells, on the other hand, had to be minimized, otherwise intracellular proteases could have become active and modified 2Abbreviations used in this paper: BSA, bovine serum albumin Cohn fraction V; IRI, immunoreactive insulin; pl, isoelectric points. Characterization of immunosorbent columns. The capacities of 1 ml immunosorbent columns were estimated by applying slowly an excess amount of insulin in 5 ml of 0.01 M Tris-HCI, pH 8.3 at 4°C, 1% BSA and measuring the difference between applied and eluted IRI in the sample volume and consecutive washings, consisting of 10 ml of application buffer, 5 ml of 1 M NaCl, and again 10 ml of application buffer. The capacity was found to be 60 mU/ml of Sepharose. After elution with a total of 15 ml of 1 M acetic acid, evaporation to dryness and dissolution in radioimmunoassay buffer, the recovery for insulin was 89%. Polyacrylamide disc gel electrophoresis. Dry samples of IRI from gel filtration, directly from the immunosorbent column or other samples, were solubilized overnight at 4°C in 200 ,ul of disc gel application buffer: N-ethylmaleimide, 1 mM; EDTA, 1 mM; NaN3, 1.5 mM; urea, 7 M; BSA, 0.25%; pH 7.6. This 200 ,ul sample was incorporated into a 5% sample gel of a pH 9.5 Ornstein-Davis disc gel (38) . The 10% running gel was 20 cm and the 4% stacking gel 1.2 cm long. During electrophoresis the temperature of the lower buffer reservoir was 18°C. Electrophoresis was terminated when the bromphenol blue band was 1 cm short of the end of the gel tube. Gels were extracted from the glass tubes, frozen, and then cut into about 90 slices of 2 mm with an automatic advance razor blade gel slicer (Joyce, Loebl and Co., Ltd. Gatesheadon-Tyne, England). Slices were extracted with 1 ml of radioimmunoassay buffer at 4°C for 4 days. A fraction of the extract was used for insulin and for proinsulin radioimmunoassays. Recovery of IRI was 84+9%. Control gels were devoid of IRI. Electrophoretic mobilities were expressed as mean R1 values relative to bromphenol blue from at least three experiments, and had a 0.005 SD.
Isoelectricfocusing. The sample ofIRI material contained in 0.2-0.8 ml of 0.1 M Tris-HCl, pH 7.4, and 1% BSA was incorporated into a 13-cm gel of 10% acrylamide, 0.6% N,N'-methylenebisacrylamide, 4% (wt/vol) ampholytes and 20 mg/l riboflavin and was polymerized by fluorescent light. The ampholytes for pH 4-7 gradients consisted of 0.5% Ampholine pH 5-7 and 1.5% Bio-Lyte pH 4-6. For pH [5] [6] [7] [8] gradients the Bio-Lyte component was substituted by one with a pH 6-8 range. Electrofocusing was carried out for 6 h in a disc gel electrophoresis apparatus (Hoefer Scientific Instruments, San Francisco, Calif.) using 0.01 M H3PO4 as anolyte and 0.02 M NaOH as catholyte. Electrofocusing gels were sliced and extracted identically to electrophoresis gels. The pH gradient was determined in gels run in parallel. The isoelectric points (pI) measured in pH units had a 0.06 SD. No component in control gels interfered with the insulin immunoassay.
Radioimmunoassays. Insulin immunoreactivity was quantitated by the radioimmunoassay of Yalow and Berson (27, 28) . Electrophoretically pure porcine insulin was used as a standard. Standards were based on a molar extinction coefficient in 0.01 M HCI of eM277nm = 60&¢') (39) . Except where mentioned, insulin immunoreactivities reported were not corrected for the differential immunoreactivity of various insulin derivatives.
Proinsulin radioimmunoassays were performed according to Kuzuya et al. (29) . Electrophoretically pure human proinsulin isolated from human pancreas extracts and assayed by the insulin radioimmunoassay was used as standard.
Trypsinization. Proinsulin-size IRI material (2-20 ng)
was trypsinized with 24 Aig of African lungfish trypsin in 0.5 ml of 0.1 M Tris-HCl pH 8.0, 0.05% NaN3, and 0.2% gelatin at 37°C for 48 h. The reaction was terminated by addition of 3 ml of 3 M acetic acid and the reaction mixture was characterized by gel filtration on Sephadex G-50 as described above. Crude soybean trypsin inhibitor (30 ,ug) was added to each fraction to be radioimmunoassayed. Characterization of reference proinsulin and insulin derivatives. The disc gel electrophoretic mobility at pH 9.5 for a number of pure proinsulin and insulin derivatives was determined. A typical experiment is shown in Fig. 2 .
Rf values relative to bromphenol blue for all available porcine and human derivatives of known constitution were fitted by the method of least squares to the empirical relationship
wherein A, B, and C are unknown empirical numbers, M is the molecular weight and z is the net negative charge of the insulin derivative at pH 9.5, estimated from the amino acid sequence and typical pKa values of ionizable groups involved (Fig. 3) , as explained in Fig. 1 . Human insulin differs from porcine insulin only by having threonine in position 30 instead of alanine. Thus, no electrophoretic difference was observed between the two insulins. In contrast, the two proinsulins differ by 10 residues. In particular, human proinsulin is one charge more negative and two residues longer than the porcine homologue. Thus, Rf values of human proinsulin derivatives were, in general, not identical to their porcine counterparts. derivatives of known constitution, and was therefore used for the identification of unknown peaks on disc gels. The isoelectric points of reference compounds were determined by isoelectric focusing in polyacrylamide gels. Isoelectric points of reference compounds were plotted as a function of the difference between cationic and anionic groups on the molecule (Fig. 4) . Most of the insulin derivatives fell on a straight line (Fig. 4A) . Desamidoinsulin as an exception is discussed below.
To rationalize observed pl values of standards, and for identification of unknown plasma components, pl values were interpreted in terms of the dissociation constants (Ka) of ionizable groups on the molecules. The isoelectric point of a multivalent ampholyte is determined primarily by the two closest pKa. values of ionizable groups on the ampholyte, K,, and I(,+,, that bracket the pL. The pl is given by pl = (pKI, + pK,,+,)/2.
(2) The subscript n is equal to the maximum positive charge the ampholyte may assume, and the pKI values are counted in increasing order starting with the most acidic one (40) . The equal spacing of pl values for insulin derivatives in Fig. 4A suggested that the pKI values that determine the pl were similarly spaced. Taking the pKI values to be the mean of two neighboring pI values appeared in this case to yield a good estimate. Attempts to refine these values by a more complete equation for the isoelectric point (40) did not yield significant changes. monoarginylinsulin is seven, its pl is between the pK5's of the seventh and the eighth ionizable groups from the acid end point, i.e., between pK4's of the two histidinyl residues. Our pI value for this compound (pI = 6.4) was in good agreement with the mean pKI of 6.4 found by titration (41) . Moreover, extrapolation of the straight line in Fig. 4A predicted a value of 7.5 for the mean pK,'s of the two a-amino groups, a value identical with that obtained by titration (41) and only slightly deviating from that obtained by chemical modification studies, i.e., 7.4 (43) .
Interpretation of the pl value of desamidoinsulin required special consideration. Slobin explains rationally why the creation of an additional negative charge in desamidoinsulin is not equivalent in terms of pI to the loss of a positive charge (e.g., monobiotinylinsulin). In contrast to the situation with insulin derivatives, pl values of proinsulin derivatives plotted as a function of the difference between cationic and anionic groups on the molecule did not yield a single straight line (Fig. 4B) . Twochain proinsulin derivatives ofporcine origin and, anticipating later identification, their human counterparts fell on a smooth curve. The two intact proinsulins lay slightly above that curve. This situation did not allow the pI values to be easily interpreted in terms of pK4 values, as it was done for insulin derivatives above. Moreover, human compounds are more acidic than porcine products, due to the additional aspartic acid residue (position 36) in the C-peptide and would thus be expected to be offset by one toward the left in Fig. 4B . Human derivatives that fulfilled that expectation were indeed observed ( Fig. 4B and Results).
RESULTS
Insulin levels. To allow extensive characterization of even minor components of human circulating IRI from individual donors, blood samples of 240 ml were taken. Insulin levels were stimulated by oral glucose (75 g) followed by intravenous arginine (30 g) as described in Methods. In addition to yielding more IRI, the stimulated state was also more likely to show any insufficiencies or defects of proinsulin-to-insulin conversion. The plasma IRI levels ranged from 52 ,uU/ml to 460 ,uU/ml, yielding between 6,300 and 57,000 ,uU of IRI for characterization.
Immunoextraction of human plasma. Plasma rather than serum was chosen for extraction of IRI to circumvent potential alterations of IRI components by the proteolytic enzymes of the coagulation system. For the same reason, coagulation was inhibited by a complex mixture of protease inhibitors (see Methods and Table I ).
Human plasma IRI was extracted by an immunosorbent column (36) so as to separate it from large amounts of proteins, including proteases and their precursors. Elimination of excess protein was also required for disc gel electrophoresis and isoelectric focusing. Insulin antibodies were covalently coupled to agarose by cyanogen bromide (44) , and to Affi-Gel 10 and CH-Sepharose 4B, two commercial affinity chromatography gels. All three affinity columns adsorbed porcine insulin and proinsulin quantitatively and gave good recoveries for insulin. Unexplainably only the last of the three gave good recoveries for proinsulin, and was thus used in this study. Human plasma IRI could be extracted quantitatively with this column, and apparent recoveries ranged from 80 to 100%.
Identification of human IRI compounds. Human plasma IRI compounds eluted from the insulin immunosorbent column were first fractionated on Sephadex G-50 (Fig. 5) jected to disc gel electrophoresis (Fig. 6A) . 80% or more of the material migrated as a sharp peak with the mobility (Rf = 0.69) of authentic human or porcine insulin. A faster moving component formed a broad band covering the Rf range expected for monodesamido-and desoctapeptide-insulin. Each of the two peaks was subjected individually to isoelectric focusing on polyacrylamide gels (Fig. 7A and B) .
Results from the large peak (Fig. 7A) showed that the major component was indeed insulin (pl = 5.7). It was however accompanied by variable amounts of material with pl values of 5.1, 5.6, 4.5, and 5.4 listed in order of decreasing relative size. Only the minor peak with pI = 5.4 was consistent with a previously identified natural product, i.e., monodesamidoinsulin. On the basis of Fig. 4 , the two larger peaks (pI = 5.1 and 4.5) appeared to carry one and two positive charges less than insulin, a difficult proposition. When the small electrophoretic peak material from Fig. 6A was subjected to isoelectric focusing (Fig. 7B) , a similar pattern was observed as when large electrophoretic peak material from Fig. 6A was focused (Fig. 7A) . The proportions of peaks differed, and the peak of insulin was much smaller. On refocusing of material from both the insulin peak (pl = 5.7) and the pl = 5.1 peak similar patterns were obtained. This demonstrated that these peaks are in part interconvertible and thus artefactual, although we have been unsuccessful in identifying the nature of the artefact. Minor quantities of such products as deamidated insulin may have been present, but we concluded that the maJor part of the insulin-size material of Fig. 5 was insulin. Finally direct disc gel electropherograms of plasma immunoextract IRI of certain subjects showed peaks in the position where diarginylinsulin runs, as well as other miscellaneous peaks (data not shown). None of these contained enough material to allow further characterization. The proinsulin-size material from gel filtration (Fig.  5 ) (elution volume/void volume = 1.56) was subjected to disc gel electrophoresis (Fig. 6B) . The insulin immunoassay showed three major (Rf = 0.47, 0.64, and 0.71) and a few minor peaks (Rf = 0.50, 0.61, and 0.79). One of them (Rf = 0.71) had the mobility of insulin (Rf = 0.70). On gel filtration of this material most of the IRI was the size of insulin. We thus concluded that this electrophoretic peak was predominantly insulin contaminating our proinsulin-size matqrial. Two major peaks (Rf = 0.47 and 0.64) and one minor peak (Rf = 0.50), observed in both the insulin and proinsulin radioimmunoassays, were further characterized. The peak with Rf = 0.47 ran on electrophoresis where human proinsulin was predicted based on amino acid sequence and Fig. 3 . The electrophoretic mobility and isoelectric points were identical with those of purified human pancreatic proinsulin. Upon trypsinization the material converted to insulin-size material. We therefore identified it as authentic human proinsulin.
The second major peak (Rf = 0.64) from disc gel electrophoresis (Fig. 6B) had the mobility predicted for desdipeptide proinsulin according to amino acid sequence and Fig. 3 (predicted Rf = 0.64), and was distinct from that predicted for desnonapeptide proinsulin (predicted Rf = 0.62). Isoelectric focusing of the same material showed a major peak with pl = 4.7, accompanied by a very small peak with pI = 4.5. Both peaks registered on the proinsulin assay. Trypsinization of the pI = 4.7 material yielded insulin-size material. The other peak contained too little material for this test. Assuming that the isoelectric points of human proinsulin derivatives would show a dependence on the difference between number of cationic and anionic groups parallel to their porcine counterparts (Fig. 4B) , the pl = 4.7 material had to be interpreted as human desdipeptide proinsulin accompanied by a small amount of the deamidated form with pI = 4.5.
On disc gel electrophoresis of proinsulin-size material from gel filtration, there was always present a minor peak with Rf = 0.50 (Fig. 6B) . Its mobility, reactivity with the proinsulin antibody and pl of 5.3 ( Fig. 4B) identified it as split proinsulin. Finally there was a small peak with Rf = 0.61. This material could be desnonapeptide proinsulin, although lack of sufficient amounts precluded further characterization.
Abbreviated characterization of human plasma IRI. In an attempt to provide a shorter method for characterizing human plasma IRI, which could also be performed with as little as 50 ml of blood, immunoextracted plasma IRI was directly applied to disc gel electrophoresis. The plasma of six subjects was analyzed. A typical disc gel electrophoresis pattern of plasma IRI is shown in Fig. 8 . Most of the immunoreactivity migrated as does authentic insulin (Rf = 0.70). However, a number of minor components were present, that could constitute up to 15% of the total IRI. Invariably, there was a peak of material that had a slightly lower electrophoretic mobility than insulin and moved so close to insulin that it could be resolved only by disc gels of 20 cm length (Rf = 0.65).
This component was identified as desdipeptide proinsulin as described above. Proinsulin (Rf = 0.48) was always present, but was often smaller than the desdipeptide peak. Sometimes there were additional minor peaks with lower mobilities than insulin, in particular split proinsulin (Rf = 0.55). The occasional appearance of a series of unresolved peaks with higher mobility than insulin, which we believe to be artefactual (see above) were also noted. Whereas, expectedly the total amount of insulin immunoreactivity varied considerably between individuals, the electrophoretic patterns ofall subjects tested were essentially the same.
DISCUSSION
With an expanded set of techniques we have demonstrated that stimulated IRI in human plasma is heterogeneous not only in size (Fig. 5) , but also in electrophoretic mobility ( Fig. 6 and 8 ) and isoelectric point (Fig. 7) . We demonstrated that the proinsulin-size fraction consisted of at least four constituents which we could partially identify. Ultimate identification would require isolation of sufficient material of each con- Gutman et al. (23) reported data to show that the proinsulins from the two species move the same on disc gel electrophoresis, whereas Oyer et al. (5) showed that human proinsulin moves faster than bovine (and thus, also porcine) proinsulin. We also found such a difference. Moreover, the former authors report no separation of proinsulin from split proinsulin, again products differing by one charge, whereas we as well as Chance (14) found that the two components separated nicely. Finally, desdiand desnonapeptide proinsulin resolved poorly, because size difference compensated for charge difference (Fig. 3) , whereas Lazarus et In the present work IRI compounds identified by gel filtration, proinsulin radioimmunoassay, trypsin sensitivity, and disc gel electrophoresis were further characterized by isoelectric focusing. Porcine pancreatic standards as well as mono-, di-, and triacylated insulins (25) (46) , whereas in the bovine cleavage at C2 (Fig. 1) yielding [seco-56/57]proinsulin seems to be preferred (13, 14) . Human pancreas seems to contain (46) and secrete (29) a small amount of C-peptide fragment originating from a chymotryptic cleavage at C2 (Fig. 1) . Although possibly present, the quantities of desnonapeptideproinsulin, the presumed precursor of the fragment, were insufficient for identification by isoelectric focusing. We suspect that chymotryptic cleavage is not an essential requirement for proinsulin activation, but is an inconsequential parallel occurrence.
In the insulin-size fraction of plasma IRI we found that true insulin constituted the predominant species. Some truly minor electrophoretic peaks in the position of diarginylinsulin and monodesamidoinsulin were occasionally observed.
It is currently thought that insulin is synthesized on the ribosome as preproinsulin, a molecule larger than proinsulin (48-51). Gorden et al. (52) have described material larger than proinsulin in a patient with islet cell carcinoma. Humbel et al. (53) and Nolan et al. (11) described proinsulin-size immunoreactive material that could not be converted to insulin-gHze material by trypsinization ("nonconvertible dimer"). In our subjects no such material was detected.
Melani et al. (54) succeeded in converting small amounts of proinsulin to insulin using bovine trypsin, while we could not consistently achieve this conversion. Prolonged digestion did not improve the results. Because we suspected autolysis, alteration of substrate specificity, and ultimate inactivation of bovine trypsin (55) to be the cause, we chose to use African lungfish trypsin, which is completely stable (30) to self-degradation.
The presence of significant amounts of desdipeptide and split proinsulin poses an interesting problem concerning the pathway of proinsulin-to-insulin conversion. There is little doubt that tryptic cleavage of proinsulin followed by carboxypeptidase B-like removal of carboxyterminal arginyl and lysyl residues is the predominant pathway. Thus, [desdipeptide-(64, 65), seco-63/66]proinsulin could well be an intermediate of the predominant pathway of proinsulin activation, as suggested by Kemmler et al. (9, 18) . Alternatively, proinsulin could be predominantly activated by first splitting between residues 32 and 33 and only later splitting between residues 65 and 66. In vitro experiments with pancreatic trypsin do not allow us to speak to this point. In (11, 14, 45) and inferred to be produced in humans as well (29, 46) . A decision in favor of one of the two possible pathways will have to await further studies.
In summary, we have shown that human plasma IRI is more heterogeneous than previously recognized, and we have identified multiple components that are analogous to those isolated from animal pancreas. Finally, we have developed an approach that is suited to address the question of whether in certain forms of diabetes mellitus with normal IRI levels there are abnormal insulin species, or excessive amounts of proinsulin-insulin intermediates in circulation. Work in that direction is in progress.
